Full Press Release Details
MARLBOROUGH, Mass. , July 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will webcast its conference call discussing financial results, business highlights and outlook for the second quarter ended June 30, 2014 on Thursday, July 24, 2014 at 8:00 a.m. ET .
The call will be hosted by Mike Mahoney , president and chief executive officer, and Dan Brennan , executive vice president and chief financial officer.
A live webcast of the conference call will be available via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors . Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
The webcast is also being distributed over Thomson Reuters Investor Distribution Network via two locations: www.earnings.com , which is accessible to the public, and www.streetevents.com , a password-protected event management site.
An archived replay of the webcast will be accessible at www.bostonscientific.com/investors approximately one hour following the completion of the conference call and available for approximately one year.
The company will issue a news release announcing financial results for the second quarter on Thursday, July 24, 2014 , prior to the conference call.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook .
CONTACTS Media: Denise Kaigler 508-683-4449 (office) Corporate Affairs & Communications Boston Scientific Corporation [email protected]
Investors: Susie Lisa , CFA 508-683-5565 (office) Investor Relations Boston Scientific Corporation [email protected]
SOURCE Boston Scientific Corporation